Radiopharmaceutical Theranostics Market – Asia-Pacific Expands Nuclear Medicine Infrastructure
North America is the largest regional market for radiopharmaceutical theranostics, accounting for approximately 45% of global demand. Its leadership is supported by advanced oncology infrastructure, strong research investment, nuclear medicine capacity, and regulatory support for innovative therapies. Europe is the second-largest market, representing around 30% of global demand. Germany,...
0 Comments 0 Shares 97 Views 0 Reviews